To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2005
In HIV patients, fasting insulin levels decrease with chromium supplementation. This study is to determine if chromium nicotinate supplementation at 400ug/day for 16 weeks will improve insulin resistance in HIV patients with metabolic abnormalities.
Epistemonikos ID: 3431a857feaac4fa04e9e732beb77f4c1a6c5e20
First added on: Dec 01, 2021